# Alzheimer's and Dementia Care: Current State

## Present Conditions

### Prevalence Overview

Alzheimer's disease and related dementias affect a growing number of Americans as the population ages. The disease burden is concentrated among older adults but affects families across generations.

| Population | Prevalence | Notes |
|------------|------------|-------|
| Age 65-74 | 5% | Early-stage often undiagnosed |
| Age 75-84 | 13% | Most common diagnosis age |
| Age 85+ | 33% | Highest risk group |
| Under 65 | ~200,000 | Early-onset Alzheimer's |
| All ages total | 6.7+ million | Alzheimer's only |

### Types of Dementia

| Type | Percentage | Characteristics |
|------|------------|-----------------|
| Alzheimer's disease | 60-80% | Progressive memory loss, most common |
| Vascular dementia | 10-15% | Often post-stroke, stepped decline |
| Lewy body dementia | 5-10% | Visual hallucinations, movement issues |
| Frontotemporal dementia | 5-10% | Behavior and personality changes |
| Mixed dementia | 10%+ | Multiple pathologies |

## Key Data

### Diagnosis and Detection

| Metric | Value | Implication |
|--------|-------|-------------|
| Undiagnosed cases | ~50% | Many never formally diagnosed |
| Average time to diagnosis | 2.5-3 years from symptoms | Significant delay |
| Diagnosed in primary care | ~75% | Not specialists |
| Cognitive screening at wellness visits | Variable | Not consistently offered |
| Medicare beneficiaries with cognitive assessment | 25% | Low screening rates |

### Care Settings

| Setting | Percentage | Notes |
|---------|------------|-------|
| Living at home | 70% | Most prefer to stay home |
| Living alone | 25% | High safety risk |
| In nursing facilities | 30% | Higher stages |
| Memory care units | 15% | Specialized facilities |
| Hospice (at death) | 55% | Lower than other conditions |

### Medicare and Medicaid Spending

| Category | Annual Spending |
|----------|-----------------|
| Medicare total (Alzheimer's) | $161 billion |
| Medicaid total (Alzheimer's) | $45 billion |
| Medicare per beneficiary | $28,000 (vs. $11,000 average) |
| Medicaid per beneficiary | $25,000 (vs. $8,600 average) |
| Skilled nursing facility | $34 billion |
| Home health | $12 billion |

### Hospitalizations

| Metric | Rate |
|--------|------|
| Annual hospital admissions | 540,000 |
| Avoidable hospitalizations | 23% |
| ED visits annually | 2.8 million |
| Average hospital stay | 5.8 days |
| 30-day readmission rate | 22% |

## Caregiver Status

### Caregiver Demographics

| Characteristic | Percentage |
|----------------|------------|
| Female | 61% |
| Spouse | 25% |
| Adult child | 55% |
| Age 65+ | 34% |
| Working (full or part-time) | 60% |
| Living with care recipient | 29% |

### Caregiver Burden

| Metric | Value |
|--------|-------|
| Average hours/week | 30 |
| High-intensity caregivers (20+ hrs) | 60% |
| Reporting high stress | 59% |
| Reporting depression | 40% |
| Physical health decline | 23% |
| Career impact (reduced hours, quit) | 70% |

### Financial Impact on Families

| Impact | Average Amount |
|--------|----------------|
| Out-of-pocket costs | $12,000/year |
| Lost income (caregivers) | $47,000 career impact |
| Foregone savings | $28,000/year |
| Women's retirement impact | $142,000 |
| Spending down to Medicaid | 50% of nursing home residents |

## Geographic Variation

### State Variation

| Category | States |
|----------|--------|
| Highest prevalence | Florida, Arizona, Maine, Vermont |
| Lowest prevalence | Alaska, Utah, Wyoming |
| Best caregiver support | California, New York, Washington |
| Least caregiver support | Mississippi, West Virginia, Idaho |

### Urban-Rural Divide

| Factor | Urban | Rural |
|--------|-------|-------|
| Access to neurologist | Higher | Much lower |
| Memory care facilities | Available | Scarce |
| Caregiver support groups | Widely available | Limited |
| Telehealth options | Growing | Connectivity barriers |
| Specialized training | More common | Rare |

## Recent Trends

### Prevalence Trends

| Period | Trend |
|--------|-------|
| 2000-2010 | Age-adjusted incidence declined |
| 2010-2020 | Absolute numbers rose (aging population) |
| 2020-2025 | Accelerating growth as baby boomers age |
| 2025-2050 | Projected near-doubling of cases |

### Treatment Developments

| Year | Development |
|------|-------------|
| 2021 | Aducanumab (Aduhelm) FDA approval—controversial |
| 2023 | Lecanemab (Leqembi) approved—modest slowing |
| 2024 | Donanemab expected approval |
| Ongoing | Multiple other trials in progress |

### Policy Changes

| Year | Policy |
|------|--------|
| 2011 | National Alzheimer's Project Act |
| 2012 | National Plan to Address Alzheimer's Disease |
| 2018 | BOLD Infrastructure Act |
| 2020 | Medicare covers cognitive assessment |
| 2023 | Medicare coverage debates for new drugs |

## Care Quality

### Nursing Home Quality for Dementia

| Metric | Finding |
|--------|---------|
| Staff training in dementia | Highly variable |
| Antipsychotic use | 15% (reduced from 24%) |
| Physical restraint use | <2% (reduced from 5%) |
| Specialized memory care | 30% of facilities |
| Person-centered care adoption | Variable |

### Home and Community Care

| Factor | Status |
|--------|--------|
| Adult day services | Available in most urban areas |
| Respite care access | Insufficient supply |
| Home modification programs | Limited funding |
| Care coordination | Fragmented |
| Telehealth for caregivers | Growing |

## Research Landscape

### Federal Funding Trajectory

| Year | NIH Funding |
|------|-------------|
| 2015 | $631 million |
| 2018 | $2.3 billion |
| 2021 | $3.1 billion |
| 2024 | $3.7 billion |
| Goal | $6 billion+ |

### Research Focus Areas

| Area | Investment |
|------|------------|
| Basic science | 30% |
| Drug development | 35% |
| Care and caregiving | 15% |
| Diagnosis/biomarkers | 15% |
| Prevention | 5% |

### Clinical Trials

| Metric | Value |
|--------|-------|
| Active trials | 150+ |
| Participants needed annually | 200,000+ |
| Recruitment success rate | 30% |
| Minority participation | <10% |
| Trial completion rate | 15% |

## Workforce Capacity

### Specialist Availability

| Specialist Type | Number | Shortage |
|-----------------|--------|----------|
| Geriatricians | 7,500 | 26,000 short |
| Geriatric psychiatrists | 1,800 | 4,000 short |
| Neurologists (dementia-focused) | ~5,000 | Significant |
| Dementia-trained nurses | Insufficient | Unknown |

### Training Gaps

| Issue | Status |
|-------|--------|
| Medical school dementia education | 2-4 hours average |
| Nursing curriculum | Minimal |
| Direct care worker training | 75 hours (little dementia) |
| Caregiver training programs | Variable access |

## Support Services

### Available Services

| Service | Availability |
|---------|--------------|
| Alzheimer's Association chapters | All 50 states |
| 24/7 helpline | National |
| Caregiver support groups | Most communities |
| Adult day centers | Urban areas mostly |
| Respite care | Insufficient |
| Care navigation | Limited |

### Gaps in Services

| Gap | Impact |
|-----|--------|
| Respite shortage | Caregiver burnout |
| Rural service access | Geographic isolation |
| Cultural competence | Minority communities underserved |
| Nighttime care | Limited options |
| Young-onset services | Age-inappropriate options |

## Legal and Safety Issues

### Driving and Safety

| Issue | Status |
|-------|--------|
| Driving cessation | Often delayed; difficult conversations |
| State reporting requirements | Variable (mandatory in 6 states) |
| DMV cognitive testing | Inconsistent |
| Wandering technology | Growing use |
| Financial exploitation | High risk |

### Legal Planning

| Document | Completion Rate |
|----------|----------------|
| Durable power of attorney | ~50% |
| Healthcare proxy | ~50% |
| Living will/advance directive | ~40% |
| Guardianship (when needed) | Costly, traumatic |

---

## Document Navigation

- Previous: [Overview](01-overview.md)
- Next: [History](03-history.md)
